Patent · US Expired

Expression of human immunodeficiency virus (HIV) reverse transcriptase

US5202259A · kind A · utility

4Cited by

3References

3Claims

0Family size

Assignee

The Trustees of Columbia University in the City of New York · US

Inventors

Stephen P. Goff · Orefield, US
Naoko Tanese · New York, US

Key dates

Filing date	Dec 28, 1988
Grant date	Apr 13, 1993
Priority date	—
Expiry date	Dec 28, 2008

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A90/10
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

This invention provides a plasmid identified as pHRTRX2 and deposited in E. coli HB101 under ATCC Accession No. 67828. The invention also provides for a polypeptide having HIV reverse transcriptase activity and for a method by which the polypeptide can be prepared which comprises growing a host cell comprising the plasmid pHRTRX2 under suitable conditions permitting production of the polypeptide and recovering the resulting polypeptide.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.